ArticleBMC infectious diseases2026
Investigating respiratory infection as a post-COVID-19 condition using a large passive surveillance cohort from Track PCC.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis study examined risk factors for post-COVID respiratory infection using data from the Tracking the Burden, Distribution, Impact of Tracking Post-COVID-19 Conditions in Diverse Populations for Children, Adolescents, Adults (Track PCC) passive surveillance cohort.
methodsThis retrospective study included adult Temple Health patients in Philadelphia, Pennsylvania with SARS-CoV-2 (COVID-19) infections from March 2020 to December 2022 and ≥ 90 days follow-up. COVID-19 infection was identified via laboratory testing, billing codes, or clinical documentation. The primary outcome was post-COVID respiratory infection identified by billing codes. Predictors included social, clinical, and COVID-related correlates. Adjusted logistic regression models were used on 17,539 complete cases and multiple imputed datasets (n = 45,513) with SuperMICE.
resultsIn complete-case analysis, uninsured coverage, Alpha variant, total comorbidities, and hospitalization were associated with lower odds of respiratory post-COVID conditions (ORs: 0.02-0.99). Dual Medicare/Medicaid and current smokers, increased odds (ORs: 1.33-1.58). Imputed analyses showed consistent results with and additionally observed higher odds of respiratory infection among those with Medicaid and higher number of vaccinations, and lower odds among those of any non-white race, Hispanic ethnicity.
conclusionsTemple Track PCC findings identify high-risk populations and underscore the utility of advanced imputation in surveillance-based research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.